Proqr Thrapeutics N V shs euro shares owned by UBS Group
Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Proqr Thrapeutics N V shs euro
Tip: Access up to 7 years of quarterly data
All positions including Proqr Thrapeutics N V shs euro held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Proqr Thrapeutics N V shs euro by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $201k | 95k | 2.13 |
| 2025-06-30 | $2.3M | 1.1M | 2.04 |
| 2025-03-31 | $2.4M | 1.8M | 1.33 |
| 2024-12-31 | $6.1M | 2.3M | 2.65 |
| 2024-09-30 | $5.3k | 2.9k | 1.82 |
| 2024-06-30 | $46k | 28k | 1.66 |
| 2024-03-31 | $11k | 5.0k | 2.29 |
| 2023-12-31 | $7.7k | 3.9k | 1.98 |
| 2023-09-30 | $13k | 10k | 1.30 |
| 2023-06-30 | $7.6k | 4.7k | 1.62 |
| 2023-03-31 | $7.7k | 3.6k | 2.13 |
| 2022-12-31 | $11k | 2.9k | 3.70 |
| 2022-09-30 | $4.0k | 5.1k | 0.78 |
| 2021-12-31 | $675k | 84k | 8.00 |
| 2021-09-30 | $788k | 94k | 8.37 |
| 2021-06-30 | $418k | 62k | 6.74 |
| 2021-03-31 | $599k | 91k | 6.61 |
| 2020-12-31 | $2.0M | 472k | 4.20 |
| 2020-09-30 | $2.3M | 478k | 4.79 |
| 2020-06-30 | $2.9M | 482k | 6.08 |
| 2020-03-31 | $2.7M | 483k | 5.49 |
| 2019-12-31 | $5.0M | 508k | 9.91 |
| 2019-09-30 | $2.6M | 452k | 5.76 |
| 2019-06-30 | $4.2M | 467k | 9.10 |
| 2018-12-31 | $45M | 2.9M | 15.78 |
| 2018-09-30 | $4.0k | 226 | 17.70 |
| 2018-03-31 | $9.0k | 2.9k | 3.11 |
| 2017-12-31 | $6.0k | 1.9k | 3.17 |
| 2017-09-30 | $12k | 2.4k | 4.98 |
| 2017-06-30 | $9.0k | 1.8k | 5.10 |
| 2016-12-31 | $6.0k | 1.3k | 4.67 |
| 2016-06-30 | $13k | 2.6k | 4.95 |
| 2015-12-31 | $8.0k | 957 | 8.36 |
| 2015-09-30 | $18k | 1.2k | 14.96 |
| 2015-03-31 | $12k | 527 | 23.62 |
Top funds holding Proqr Thrapeutics N V shs euro
View all funds holding Proqr Thrapeutics N V shs euro